These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 34863142)

  • 1. METTL14 gene polymorphisms decrease Wilms tumor susceptibility in Chinese children.
    Zhuo Z; Hua RX; Zhang H; Lin H; Fu W; Zhu J; Cheng J; Zhang J; Li S; Zhou H; Xia H; Liu G; Jia W; He J
    BMC Cancer; 2021 Dec; 21(1):1294. PubMed ID: 34863142
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic Variants in
    Luo A; Yang L; Li M; Cai M; Huang A; Liu X; Yang X; Yan Y; Wang X; Wu X; Huang K; Huang L; Liu S; Xu L; Liu X
    Cancer Manag Res; 2021; 13():9189-9200. PubMed ID: 34934362
    [TBL] [Abstract][Full Text] [Related]  

  • 3. METTL14 gene polymorphisms influence hepatoblastoma predisposition in Chinese children: Evidences from a seven-center case-control study.
    Chen H; Chen Z; Wang M; Zhang J; Li Y; Li L; Li S; Cheng J; Wang X; Xia H; Yang Z; He J
    Gene; 2022 Jan; 809():146050. PubMed ID: 34743822
    [TBL] [Abstract][Full Text] [Related]  

  • 4. METTL3 polymorphisms and Wilms tumor susceptibility in Chinese children: A five-center case-control study.
    Lin A; Zhou M; Hua RX; Zhang J; Zhou H; Li S; Cheng J; Xia H; Fu W; He J
    J Gene Med; 2020 Nov; 22(11):e3255. PubMed ID: 32716082
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ALKBH5 gene polymorphisms and Wilms tumor risk in Chinese children: A five-center case-control study.
    Hua RX; Liu J; Fu W; Zhu J; Zhang J; Cheng J; Li S; Zhou H; Xia H; He J; Zhuo Z
    J Clin Lab Anal; 2020 Jun; 34(6):e23251. PubMed ID: 32091154
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The contribution of WTAP gene variants to Wilms tumor susceptibility.
    Ma L; Hua RX; Lin H; Zhu J; Fu W; Lin A; Zhang J; Cheng J; Zhou H; Li S; Zhuo Z; He J
    Gene; 2020 Sep; 754():144839. PubMed ID: 32504654
    [TBL] [Abstract][Full Text] [Related]  

  • 7. METTL14 Gene Polymorphisms Confer Neuroblastoma Susceptibility: An Eight-Center Case-Control Study.
    Zhuo Z; Lu H; Zhu J; Hua RX; Li Y; Yang Z; Zhang J; Cheng J; Zhou H; Li S; Li L; Xia H; He J
    Mol Ther Nucleic Acids; 2020 Aug; 22():17-26. PubMed ID: 32891980
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LMO family gene polymorphisms and Wilms tumor susceptibility in Chinese children: a five-center case-control study.
    Fu W; Deng L; Yan X; Hua RX; Zhang J; Zhou H; Deng C; Li S; Cheng J; Ruan J; He J; Liu G
    BMC Cancer; 2024 Jun; 24(1):772. PubMed ID: 38937681
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of FTO gene polymorphisms in Wilms tumor predisposition: A five-center case-control study.
    Hua RX; Fu W; Lin A; Zhou H; Cheng J; Zhang J; Li S; Liu G; Xia H; Zhuo Z; He J
    J Gene Med; 2021 Aug; 23(8):e3348. PubMed ID: 33894035
    [TBL] [Abstract][Full Text] [Related]  

  • 10. YTHDC1 gene polymorphisms and Wilms tumor susceptibility in Chinese children: A five-center case-control study.
    Lin A; Hua RX; Zhou M; Fu W; Zhang J; Zhou H; Li S; Cheng J; Zhu J; Xia H; Liu G; He J
    Gene; 2021 May; 783():145571. PubMed ID: 33737126
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of YTHDF1 gene polymorphisms on Wilms tumor susceptibility: A five-center case-control study.
    Liu Y; Lin H; Hua RX; Zhang J; Cheng J; Li S; Zhou H; Zhuo Z; Bian J
    J Clin Lab Anal; 2021 Aug; 35(8):e23875. PubMed ID: 34151473
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MYCN gene polymorphisms and Wilms tumor susceptibility in Chinese children.
    Huang X; Zhao J; Zhu J; Chen S; Fu W; Tian X; Lou S; Ruan J; He J; Zhou H
    J Clin Lab Anal; 2019 Nov; 33(9):e22988. PubMed ID: 31343784
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HMGA2 gene polymorphisms and Wilms tumor susceptibility in Chinese children: a four-center case-control study.
    Cheng J; Zhuo Z; Yang L; Zhao P; Zhang J; Zhou H; He J; Li P
    Biotechnol Appl Biochem; 2020 Nov; 67(6):939-945. PubMed ID: 31746066
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The correlation between LIN28B gene potentially functional variants and Wilms tumor susceptibility in Chinese children.
    Fu W; Liu GC; Zhao Z; Zhu J; Jia W; Zhu SB; Hu JH; Wang FH; He J; Xia H
    J Clin Lab Anal; 2018 Jan; 32(1):. PubMed ID: 28301057
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LIN28A gene polymorphisms confer Wilms tumour susceptibility: A four-centre case-control study.
    Zhuo Z; Fu W; Liu J; Cheng J; Zhou H; Zhang J; Zhu JH; Xia H; Liu G; He J
    J Cell Mol Med; 2019 Oct; 23(10):7105-7110. PubMed ID: 31338973
    [TBL] [Abstract][Full Text] [Related]  

  • 16. H19 gene polymorphisms and Wilms tumor risk in Chinese children: a four-center case-control study.
    Li W; Hua RX; Wang M; Zhang D; Zhu J; Zhang S; Yang Y; Cheng J; Zhou H; Zhang J; He J
    Mol Genet Genomic Med; 2021 Feb; 9(2):e1584. PubMed ID: 33403826
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TRMT6 gene rs236110 C > A polymorphism increases the risk of Wilms tumor.
    Chang X; Zhu J; Hua RX; Deng C; Zhang J; Cheng J; Li S; Zhou H; He J; Wang H
    Gene; 2023 Oct; 882():147646. PubMed ID: 37473973
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    Deng L; Hua RX; Deng C; Zhu J; Zhang Z; Cheng J; Zhang J; Zhou H; Li S; Ruan J; Liu G; He J; Fu W
    J Cancer; 2023; 14(8):1293-1300. PubMed ID: 37283791
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association Between HACE1 Gene Polymorphisms and Wilms' Tumor Risk in a Chinese Population.
    Jia W; Deng Z; Zhu J; Fu W; Zhu S; Zhang LY; Hu J; Wang F; Xia H; Liu GC; He J
    Cancer Invest; 2017 Nov; 35(10):633-638. PubMed ID: 29243987
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of
    Fu W; Zhuo Z; Hua RX; Fu K; Jia W; Zhu J; Zhang J; Cheng J; Zhou H; Xia H; He J; Liu G
    Aging (Albany NY); 2019 Mar; 11(5):1551-1563. PubMed ID: 30860980
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.